Medicone Formulations Private Limited - Company Profile

It is a healthcare private limited company based in New Delhi, Delhi, India, established in 2001.
2001 New Delhi, Delhi, India Active
Last Updated:
Access Report
About Medicone Formulations Private Limited

Medicone Formulations Private Limited, a active private limited company, was established on 22 February 2001 in New Delhi, Delhi, India. Engaging in medical equipment retail & distribution within the trade sector, it holds CIN: U24231DL2001PTC109768. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.

It upholds a compliant status. Its leadership includes Sankalp Bansal (Director), Seema Bansal (Director), Nalin Kumar Bansal (Director). Past directors included Gaurav Bhargava, Sunil Bhargava. It holds ₹7.90 M open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at J-12/71-A Ist Floorrajouri Garden, New Delhi, Delhi, 110027.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24231DL2001PTC109768

  • Registration Number

    109768

  • Incorporation Date

    22 February 2001

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.50 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.50 M
  • Company Age 24 Year, 11 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 7.90 M
  • Revenue Growth **** 21.93%
  • Profit Growth **** 115.54%
  • Ebitda **** 255.18%
  • Net Worth 23.58%
  • Total Assets -4.12%
Company report

Medicone Formulations Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Medicone Formulations Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Medicone Formulations Private Limited?
Current Directors
Name Designation Appointment Date Status
Sankalp Bansal Director 30 Jun 2005 Current
Seema Bansal Director 30 Jun 2009 Current
Nalin Kumar Bansal Director 22 Feb 2001 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 30 Jun 2009 Past
Pramod Abcsdd Director 30 Jun 2009 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Medicone Formulations.

Medicone Formulations Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 21.93% increase. The company also saw a substantial improvement in profitability, with a 115.54% increase in profit. The company's net worth Soared by an impressive increase of 23.58%.

Medicone Formulations revenue growth over time
Medicone Formulations profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 21.93%
*******
*******
*******
*******
Revenue from Operations
*******
 21.93%
*******
*******
*******
*******
Total Assets
*******
 -4.12%
*******
*******
*******
*******
Profit or Loss
*******
 115.54%
*******
*******
*******
*******
Net Worth
*******
 23.58%
*******
*******
*******
*******
EBITDA
*******
 255.18%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Medicone Formulations?

Unlock access to Medicone Formulations's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹7,900,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Axis Bank Limited : 0.35 Cr
  • Others : 0.34 Cr
  • Punjab & Sind Bank : 0.10 Cr
Latest Charge Details
Date Lender Amount Status
30 Sep 2021 Axis Bank Limited ₹3.50 M Open
13 Sep 2021 Others ₹3.40 M Open
14 Feb 2011 Punjab & Sind Bank ₹1.00 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Medicone Formulations?

Unlock and access historical data on people associated with Medicone Formulations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Medicone Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medicone Formulations's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Medicone Formulations
Recent Activity within the Organization
  • Annual General Meeting

    Medicone Formulations Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Medicone Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was recorded as a recent event.

  • Charges

    The activity A charge with Axis Bank Limited amounted to Rs. 3.50 M with Charge ID 100487933 was registered on 30 Sep 2021. was completed.

  • Charges

    Progress on A charge with Others amounted to Rs. 3.40 M with Charge ID 100476764 was registered on 13 Sep 2021. was documented.

  • Charges

    The activity A charge with Punjab & Sind Bank amounted to Rs. 1.00 M with Charge ID 10271271 was registered on 14 Feb 2011. was completed.

  • Director Appointment

    The activity Seema Bansal was appointed as a Director was appointed as a Director on 30 Jun 2009 & has been associated with this company since 16 years 7 months . was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Medicone Formulations Private Limited?

The CIN of Medicone Formulations Private Limited is U24231DL2001PTC109768.

Where is Medicone Formulations Private Limited headquartered?

Medicone Formulations Private Limited is headquartered at J-12/71-A Ist Floorrajouri Garden, New Delhi, Delhi, 110027.

When was Medicone Formulations Private Limited incorporated?

Medicone Formulations Private Limited was incorporated on 22 February 2001.

Who are the current directors of Medicone Formulations Private Limited?

The current directors of Medicone Formulations Private Limited are

What is the primary industry of Medicone Formulations Private Limited?

The primary industry of Medicone Formulations Private Limited is Trade.

Is Medicone Formulations Private Limited a listed company?

Medicone Formulations Private Limited is unlisted.

What is the capital structure of Medicone Formulations Private Limited?

The authorized capital of Medicone Formulations Private Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.

What is the compliance status of Medicone Formulations Private Limited?

The compliance status of Medicone Formulations Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available